NCT02853916View on ClinicalTrials.gov

Efficacy of a Brown Seaweed Powder for Glycemic Control

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

October 25, 2017

Conditions
Blood Glucose
Interventions
DIETARY_SUPPLEMENT

500 mg InSea2®

DIETARY_SUPPLEMENT

250 mg InSea2®

DIETARY_SUPPLEMENT

Placebo

Trial Locations (1)

R3T 2N2

Richardson Centre for Functional Foods and Nutraceuticals, Winnipeg

All Listed Sponsors
collaborator

innoVactiv Inc.

INDUSTRY

lead

University of Manitoba

OTHER

NCT02853916 - Efficacy of a Brown Seaweed Powder for Glycemic Control | Biotech Hunter | Biotech Hunter